Phase I and pharmacokinetic study of the oral histone deacetylase inhibitor vorinostat in Japanese patients with relapsed or refractory cutaneous T-cell lymphoma.
about
A phase I study of vorinostat combined with bortezomib in Japanese patients with relapsed or refractory multiple myeloma.Current therapy of choice for cutaneous lymphomas: Complementary to the Japanese Dermatological Association/Japanese Skin Cancer Society guidelines.A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model of the histone deacetylase (HDAC) inhibitor vorinostat for pediatric and adult patients and its application for dose specification.New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma.
P2860
Phase I and pharmacokinetic study of the oral histone deacetylase inhibitor vorinostat in Japanese patients with relapsed or refractory cutaneous T-cell lymphoma.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Phase I and pharmacokinetic st ...... ory cutaneous T-cell lymphoma.
@ast
Phase I and pharmacokinetic st ...... ory cutaneous T-cell lymphoma.
@en
type
label
Phase I and pharmacokinetic st ...... ory cutaneous T-cell lymphoma.
@ast
Phase I and pharmacokinetic st ...... ory cutaneous T-cell lymphoma.
@en
prefLabel
Phase I and pharmacokinetic st ...... ory cutaneous T-cell lymphoma.
@ast
Phase I and pharmacokinetic st ...... ory cutaneous T-cell lymphoma.
@en
P2093
P2860
P1476
Phase I and pharmacokinetic st ...... ory cutaneous T-cell lymphoma.
@en
P2093
Hidefumi Wada
Kazuo Noguchi
Keiji Iwatsuki
Kensei Tobinai
Makoto Sugaya
Ryoji Tsuboi
Takashi Shimamoto
Toshihisa Hamada
Yukihiko Kato
P2860
P304
P356
10.1111/J.1346-8138.2012.01554.X
P577
2012-04-16T00:00:00Z